Verseon was founded with the aim of addressing the paucity of new drugs being discovered even as the pharmaceutical industry continues to spend over $60 billion per year on research and development. We are addressing this scarcity by using our platform to engineer novel drugs consistently, reliably, and cost-effectively.

Verseon's platform is the product of an eight year long research and development effort focusing on making advancements in accurate modeling of the physics of molecular interactions, development of novel numerical algorithms, and integration and automation of decades of synthetic and medicinal chemistry knowledge.

Verseon's platform explores a chemical space of hundreds of millions to billions of new drug-like compounds and can consistently design drug candidates that simply cannot be found through other methods.

Reliable and Consistent

Systematically designs novel compounds from the structure of a disease-causing target—a major improvement over the 67% failure rate of conventional technologies

 

Rapid and Cost Effective

Shifting the focus from laboratory trial-and-error to computational design coupled with focused laboratory verification makes drug design fast and efficient